{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:03Z","timestamp":1790775723700,"version":"4.1.0"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The skin is the largest organ in the body and one of the primary barriers to the environment. In order to optimally protect the host, the skin is home to numerous immune cell subsets that interact with each other and other non-immune cells to maintain organ integrity and function. Regulatory T cells (Tregs) are one of the largest immune cell subsets in skin. They play a critical role in regulating inflammation and facilitating organ repair. In doing so, they adopt unique and specialized tissue-specific functions. In this review, we compare and contrast the role of Tregs in cutaneous immune disorders from mice and humans, with a specific focus on scleroderma, alopecia areata, atopic dermatitis, cutaneous lupus erythematosus and psoriasis.<\/jats:p>","DOI":"10.1093\/intimm\/dxz020","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T04:16:20Z","timestamp":1550636180000},"page":"457-463","source":"Crossref","is-referenced-by-count":54,"title":["Regulatory T cells in inflammatory skin disease: from mice to humans"],"prefix":"10.1093","volume":"31","author":[{"given":"Lokesh A","family":"Kalekar","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical Sciences Building, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Rosenblum","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Sciences Building, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"2022071820583827700_CIT0001","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"2022071820583827700_CIT0002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"2022071820583827700_CIT0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"2022071820583827700_CIT0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat. Genet."},{"key":"2022071820583827700_CIT0006","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"2022071820583827700_CIT0007","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Immunol."},{"key":"2022071820583827700_CIT0008","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2018.00883","article-title":"Emerging functions of regulatory T cells in tissue homeostasis","volume":"9","author":"Sharma","year":"2018","journal-title":"Front. Immunol."},{"key":"2022071820583827700_CIT0009","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue tregs","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"2022071820583827700_CIT0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.immuni.2015.10.016","article-title":"A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes","volume":"43","author":"Scharschmidt","year":"2015","journal-title":"Immunity"},{"key":"2022071820583827700_CIT0011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"2022071820583827700_CIT0012","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1172\/JCI72932","article-title":"Memory regulatory T cells reside in human skin","volume":"124","author":"Sanchez Rodriguez","year":"2014","journal-title":"J. Clin. Invest."},{"key":"2022071820583827700_CIT0013","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.chom.2017.03.001","article-title":"Commensal microbes and hair follicle morphogenesis coordinately drive treg migration into neonatal skin","volume":"21","author":"Scharschmidt","year":"2017","journal-title":"Cell Host Microbe"},{"key":"2022071820583827700_CIT0014","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"2022071820583827700_CIT0015","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","article-title":"The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors","volume":"177","author":"Hirahara","year":"2006","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0016","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4049\/jimmunol.161.2.963","article-title":"CD4+ T cells migrate into inflamed skin only if they express ligands for E- and P-selectin","volume":"161","author":"Tietz","year":"1998","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0017","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/eji.200323658","article-title":"Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells","volume":"33","author":"Iellem","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"2022071820583827700_CIT0018","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/23495","article-title":"The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells","volume":"400","author":"Campbell","year":"1999","journal-title":"Nature"},{"key":"2022071820583827700_CIT0019","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20021859","article-title":"Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen","volume":"197","author":"Alferink","year":"2003","journal-title":"J. Exp. Med."},{"key":"2022071820583827700_CIT0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20070081","article-title":"Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease","volume":"204","author":"Sather","year":"2007","journal-title":"J. Exp. Med."},{"key":"2022071820583827700_CIT0021","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1172\/JCI57456","article-title":"GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice","volume":"121","author":"Wohlfert","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2022071820583827700_CIT0022","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2022071820583827700_CIT0023","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-015-0517-1","article-title":"The immunopathology of systemic sclerosis","volume":"37","author":"van Laar","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"2022071820583827700_CIT0024","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583827700_CIT0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"2022071820583827700_CIT0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-319-31407-5_18","article-title":"Pathophysiology of fibrosis in systemic sclerosis","volume-title":"Scleroderma","author":"Trojanowska","year":"2017"},{"key":"2022071820583827700_CIT0027","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"2022071820583827700_CIT0028","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"2022071820583827700_CIT0029","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J. Exp. Med."},{"key":"2022071820583827700_CIT0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1084\/jem.20020903","article-title":"Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response","volume":"197","author":"Chiaramonte","year":"2003","journal-title":"J. Exp. Med."},{"key":"2022071820583827700_CIT0031","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"2022071820583827700_CIT0032","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma","volume":"70","author":"Klein","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"2022071820583827700_CIT0033","doi-asserted-by":"crossref","first-page":"e5981","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"2022071820583827700_CIT0034","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.imbio.2012.05.020","article-title":"Differential role of regulatory T cells in early and late stages of pulmonary fibrosis","volume":"218","author":"Boveda-Ruiz","year":"2013","journal-title":"Immunobiology"},{"key":"2022071820583827700_CIT0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2010.06.004","article-title":"Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes","volume":"137","author":"Giovannetti","year":"2010","journal-title":"Clin. Immunol."},{"key":"2022071820583827700_CIT0036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.05.013","article-title":"Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis","volume":"184","author":"Ugor","year":"2017","journal-title":"Clin. Immunol."},{"key":"2022071820583827700_CIT0037","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"2022071820583827700_CIT0038","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583827700_CIT0039","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","article-title":"Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype","volume":"110","author":"Tran","year":"2007","journal-title":"Blood"},{"key":"2022071820583827700_CIT0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int. Immunol."},{"key":"2022071820583827700_CIT0041","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development","volume":"103","author":"Gavin","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2022071820583827700_CIT0042","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2022071820583827700_CIT0043","doi-asserted-by":"crossref","first-page":"179ra43","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2022071820583827700_CIT0044","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/bloodadvances.2017011072","article-title":"Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients","volume":"2","author":"Arruda","year":"2018","journal-title":"Blood Adv."},{"key":"2022071820583827700_CIT0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/imm.12791","article-title":"Regulatory T cells in skin","volume":"152","author":"Ali","year":"2017","journal-title":"Immunology"},{"key":"2022071820583827700_CIT0046","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-017-8620-9","article-title":"Alopecia areata: a comprehensive review of pathogenesis and management","volume":"54","author":"Tr\u00fceb","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2022071820583827700_CIT0047","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"2022071820583827700_CIT0048","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10238-012-0224-3","article-title":"Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with alopecia areata","volume":"14","author":"Conteduca","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"2022071820583827700_CIT0049","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J. Dermatol."},{"key":"2022071820583827700_CIT0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol."},{"key":"2022071820583827700_CIT0051","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaci.2009.11.027","article-title":"Recent insights into atopic dermatitis and implications for management of infectious complications","volume":"125","author":"Boguniewicz","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583827700_CIT0052","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J. Exp. Med."},{"key":"2022071820583827700_CIT0053","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/jid.2012.40","article-title":"Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis","volume":"132","author":"Fyhrquist","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583827700_CIT0054","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/all.13465","article-title":"Allergen-specific immunotherapy induces regulatory T cells in an atopic dermatitis mouse model","volume":"73","author":"Shin","year":"2018","journal-title":"Allergy"},{"key":"2022071820583827700_CIT0055","doi-asserted-by":"crossref","first-page":"eaao6923","DOI":"10.1126\/sciimmunol.aao6923","article-title":"ROR\u03b1-expressing T regulatory cells restrain allergic skin inflammation","volume":"3","author":"Malhotra","year":"2018","journal-title":"Sci. Immunol."},{"key":"2022071820583827700_CIT0056","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2016.02.030","article-title":"IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function","volume":"138","author":"Noval Rivas","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583827700_CIT0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.12.016","article-title":"A mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells","author":"Van Gool","year":"2019","journal-title":"Immunity"},{"key":"2022071820583827700_CIT0058","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1172\/JCI11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2022071820583827700_CIT0059","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","article-title":"Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"160","author":"Halabi-Tawil","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"2022071820583827700_CIT0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)60170-6","article-title":"Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis","volume":"103","author":"Ito","year":"2009","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"2022071820583827700_CIT0061","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaci.2004.01.772","article-title":"T regulatory cells in atopic dermatitis and subversion of their activity by superantigens","volume":"113","author":"Ou","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583827700_CIT0062","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2007.11.003","article-title":"Analysis of CD25hiCD4+ \u201cregulatory\u201d T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population","volume":"121","author":"Reefer","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583827700_CIT0063","first-page":"1746","article-title":"Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective","volume":"68","author":"Javinani","year":"2019","journal-title":"Immunogenetics"},{"key":"2022071820583827700_CIT0064","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-0031-x","article-title":"Pathophysiology of cutaneous lupus erythematosus","volume":"33","author":"Lin","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2022071820583827700_CIT0065","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J. Exp. Med."},{"key":"2022071820583827700_CIT0066","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/art.1780210909","article-title":"Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice","volume":"21","author":"Dixon","year":"1978","journal-title":"Arthritis Rheum."},{"key":"2022071820583827700_CIT0067","doi-asserted-by":"crossref","first-page":"271694","DOI":"10.1155\/2011\/271694","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"2022071820583827700_CIT0068","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1191\/0961203303lu1002oa","article-title":"A deficiency of CD4+CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen","volume":"13","author":"Wu","year":"2004","journal-title":"Lupus"},{"key":"2022071820583827700_CIT0069","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.177.3.1451","article-title":"Suppression of disease in New Zealand Black\/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells","volume":"177","author":"Scalapino","year":"2006","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1073\/pnas.0903158107","article-title":"Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus","volume":"107","author":"Humrich","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2022071820583827700_CIT0071","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0961203314530488","article-title":"Ultraviolet radiation and systemic lupus erythematosus","volume":"23","author":"Barbhaiya","year":"2014","journal-title":"Lupus"},{"key":"2022071820583827700_CIT0072","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.4049\/jimmunol.181.10.7367","article-title":"Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice","volume":"181","author":"Menke","year":"2008","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0073","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/eji.200838190","article-title":"Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15","volume":"38","author":"Yang","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"2022071820583827700_CIT0074","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4049\/jimmunol.1002218","article-title":"Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu","volume":"186","author":"Divekar","year":"2011","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0075","doi-asserted-by":"crossref","first-page":"740619","DOI":"10.1155\/2010\/740619","article-title":"The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity","volume":"2010","author":"Lieberman","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"2022071820583827700_CIT0076","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/art.24658","article-title":"A polymorphism within IL21R confers risk for systemic lupus erythematosus","volume":"60","author":"Webb","year":"2009","journal-title":"Arthritis Rheum."},{"key":"2022071820583827700_CIT0077","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0078","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int. Immunol."},{"key":"2022071820583827700_CIT0079","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0961203307088307","article-title":"Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance","volume":"17","author":"Vargas-Rojas","year":"2008","journal-title":"Lupus"},{"key":"2022071820583827700_CIT0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2362.2007.01882.x","article-title":"The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"37","author":"Lin","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"2022071820583827700_CIT0081","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/annrheumdis-2014-206506","article-title":"Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE","volume":"74","author":"Humrich","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"2022071820583827700_CIT0082","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"2022071820583827700_CIT0083","first-page":"11","article-title":"Adoptive Treg cell therapy in a patient with systemic lupus erythematosus","volume":"37","author":"Dall\u2019Era","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"2022071820583827700_CIT0084","doi-asserted-by":"crossref","first-page":"a015354","DOI":"10.1101\/cshperspect.a015354","article-title":"Psoriasis","volume":"4","author":"Di Meglio","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2022071820583827700_CIT0085","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0086","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0087","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583827700_CIT0088","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.celrep.2018.12.012","article-title":"Regulatory T cells restrain pathogenic T helper cells during skin inflammation","volume":"25","author":"Hartwig","year":"2018","journal-title":"Cell Rep."},{"key":"2022071820583827700_CIT0089","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jdermsci.2018.08.007","article-title":"The vitamin D3 analog, maxacalcitol, reduces psoriasiform skin inflammation by inducing regulatory T cells and downregulating IL-23 and IL-17 production","volume":"92","author":"Hau","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"2022071820583827700_CIT0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"2022071820583827700_CIT0091","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin. Immunol."},{"key":"2022071820583827700_CIT0092","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1038\/s41598-018-29472-w","article-title":"RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways","volume":"8","author":"Ahn","year":"2018","journal-title":"Sci. Rep."},{"key":"2022071820583827700_CIT0093","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583827700_CIT0094","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.4147","article-title":"An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells","volume":"22","author":"Massoud","year":"2016","journal-title":"Nat. Med."},{"key":"2022071820583827700_CIT0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"2022071820583827700_CIT0096","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"2022071820583827700_CIT0097","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coi.2009.05.021","article-title":"Developmental plasticity of Th17 and Treg cells","volume":"21","author":"Lee","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"2022071820583827700_CIT0098","doi-asserted-by":"crossref","first-page":"eaau2042","DOI":"10.1126\/sciimmunol.aau2042","article-title":"The TNFRSF members CD27 and OX40 coordinately limit TH17 differentiation in regulatory T cells","volume":"3","author":"Remedios","year":"2018","journal-title":"Sci. Immunol."},{"key":"2022071820583827700_CIT0099","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583827700_CIT0100","first-page":"260","article-title":"T helper 17 cell\/regulatory T-cell imbalance in hidradenitis suppurativa\/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities","volume":"179","author":"Melnik","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"2022071820583827700_CIT0101","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coi.2013.11.002","article-title":"Organization of the mouse and human DC network","volume":"26","author":"Schlitzer","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"2022071820583827700_CIT0102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.0022-202x.2001.01377.x","article-title":"A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages","volume":"117","author":"M\u00fcller-R\u00f6ver","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583827700_CIT0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation","author":"Miragaia","year":"2019","journal-title":"Immunity"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/31\/7\/457\/45022529\/intimm_31_7_457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/31\/7\/457\/45022529\/intimm_31_7_457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:55:04Z","timestamp":1694634904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article\/31\/7\/457\/5353172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":103,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,2,20]]},"published-print":{"date-parts":[[2019,7,13]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxz020","relation":{},"ISSN":["1460-2377"],"issn-type":[{"value":"1460-2377","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,2,20]]}}}